Ann: Preliminary Final Report, page-139

Hi Oz, Know? No.

But what I have done is considered the Company Reports, especially those of this year, have noted the recent Company actions, especially those relating to the Capital Raising Targeting and new Board Composition (no medical doctors or specialists), the Option Gifting and its time frame when related to the clinical trials Company stated time frames, have looked at what I would call core and non core assets and their maybe values and costs to develop, and have done some lateral thinking about the clues which I think I see there. My opinion only. And what would I really know?

A bit akin to trying to "tying the knots" which I saw mentioned somewhere else on this forum today.

Interesting enough to keep me sticking around, and I was just being friendly to Mal who I think has been unfairly ridiculed at times.